Results 111 to 120 of about 5,962 (164)

Pathogenic mobile element insertion in the <i>MEN1</i> gene mimicking a deletion in MLPA: characterisation by long-read sequencing. [PDF]

J Med Genet
Pfeifer A, Zebracka-Gala J, Pawlaczek A, Zajkowicz A, Abramowicz A, Tecza K, Kotecka-Blicharz A, Langer-Maciol H, Cieslicka M, Rusinek D, Porc M, Cyplinska R, Oczko-Wojciechowska M.   +12 more
europepmc   +1 more source

Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review. [PDF]

Endocr J
Suda K, Kimura N, Maeda T, Watanabe S, Nishida S, Shima H, Sugawara T, Uchino S, Ishikawa A, Tanaka T, Furuhashi M, Masumori N, Sakurai A.   +12 more
europepmc   +1 more source

Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-making. [PDF]

CA Cancer J Clin
Kallas-Silva L, Dos Santos Valsecchi VA, Hoff AO, Farias EC, de Barros Maciel RM, Riera R, Ward LS, Cunha LL.   +7 more
europepmc   +1 more source

Long-Term Efficacy and Safety of GLP-1R Agonist and SGLT2 Inhibitor Therapy in the General Population: A Mendelian Randomization Study. [PDF]

Circ Genom Precis Med
Remala S, Liang L, Shah AM, Buckley LF.
europepmc   +1 more source

Mixed Medullary and Papillary Thyroid Carcinoma in a Patient on Tirzepatide. [PDF]

Cureus
Beshay LH, Makker J, Ahern S.
europepmc   +1 more source

Health-related quality of life in children with multiple endocrine neoplasia (MEN) and their siblings.

J Clin Endocrinol Metab
Zwerus D, Verrijn Stuart AA, van Santen HM, Valk GD, de Bruin C, Sas TCJ, Bocca G, Mooij CF, Claahsen-van der Grinten HL, Straetemans S, Schepers SA, van Leeuwaarde RS.   +11 more
europepmc   +1 more source

Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study.

J Clin Endocrinol Metab
Omotosho YB, Vikram NU, Wright EC, Dola V, Abbas W, Tora R, Bliss L, Cochran C, Pieper CF, Chittiboina P, Weinstein LS, Simonds WF, Biassou N, Jha S.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B

Primary Care - Clinics in Office Practice
Multiple endocrine neoplasia type 1 is a rare genetic neuroendocrine syndrome caused by over 1500 different germline mutations. It can cause 20 different endocrine tumors affecting primarily the parathyroid glands, gastroenteropancreatic tract, and the anterior pituitary gland.
exaly   +3 more sources

Multiple endocrine neoplasia type 2B

International Journal of Urology, 2001
Abstract We report a case of multiple endocrine neoplasia type 2B (MEN 2B) in a 30‐year‐old woman. There was no family history of MEN 2B in her family. DNA testing was carried out and a point mutation was found in exon 16, codon 918 (ATG to ACG) in the RET proto‐oncogene.
S, Nakata, H, Okugi, Y, Saitoh, H, Takahashi, K, Shimizu   +4 more
openaire   +2 more sources

Multiple endocrine neoplasia type 2b in twins

Histopathology, 1982
The syndrome of multiple endocrine neoplasia (MEN or MEA) type 2b is characterized by the association of medullary carcinoma of the thyroid, phaeochromocytoma, ganglioneuromatosis and Marfan‐like features. Though this disorder usually shows a familial distribution, it may also appear spontaneously as the result of a genetic mutation.
H, Galera, R, Gonzalez-Campora, A, Matilla, I, Martin   +3 more
openaire   +2 more sources